Will Evidence Ever Be Sufficient to Resolve the Challenge of Cost Containment?

被引:16
作者
Caplan, Arthur L. [1 ]
机构
[1] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA
关键词
CANCER;
D O I
10.1200/JCO.2011.34.7039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1946 / 1948
页数:3
相关论文
共 21 条
[1]  
Aitken RJ, 2009, ASIA PAC J CLIN NUTR, V18, P63
[2]  
[Anonymous], MAN COST CANC CAR PR
[3]  
[Anonymous], 2010, LANCET, V376, P389
[4]  
ARSENAULT M, 2011, BOSTON GLOBE 0211
[5]   An Evaluation Of Recent Federal Spending On Comparative Effectiveness Research: Priorities, Gaps, And Next Steps [J].
Benner, Joshua S. ;
Morrison, Marisa R. ;
Karnes, Erin K. ;
Kocot, S. Lawrence ;
McClellan, Mark .
HEALTH AFFAIRS, 2010, 29 (10) :1768-1776
[6]  
Bloche MaxwellGregg., 2011, The Hippocratic Myth: Why Doctors are Under Pressure to Ration Care, Practice Politics, and Compromise their Promise to Heal
[7]  
Buyx Alena M, 2011, BMJ, V342, pd54, DOI 10.1136/bmj.d54
[8]   Cancer and bioethics: Caring and consensus [J].
Caplan, Arthur L. .
CANCER, 2008, 113 (07) :1801-1806
[9]  
ELKIN EB, 2010, JAMA-J AM MED ASSOC, V304, P2323
[10]   GRADE:: going from evidence to recommendations [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Falck-Ytter, Yngve ;
Vist, Gunn E. ;
Liberati, Alessandro ;
Schunemann, Holger J. .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7652) :1049-1051